Evidence map›Paper›PMID 21060977›Full record

ArticleMolecular medicine (Cambridge, Mass.)

Stearoyl-CoA desaturase-1 is associated with insulin resistance in morbidly obese subjects.

Sara García-Serrano, Inmaculada Moreno-Santos, Lourdes Garrido-Sánchez, Carolina Gutierrez-Repiso, Jose M García-Almeida, Juan García-Arnés, Jose Rivas-Marín, Jose L Gallego-Perales, Eva García-Escobar, Gemma Rojo-Martinez and 4 more

Open access · goldAbstract read
In one paragraph

Article in Molecular medicine (Cambridge, Mass.). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 72 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Adipose Tissue Hypoxia in Obesity: Clinical Reappraisal of Hypoxia Hypothesis.Advances in experimental medicine and biology · 2024
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. The Antagonist Effect of Arachidonic Acid onInternational journal of molecular sciences · 2019
    Article
  16. [Research progress of stearoyl-CoA desaturase-1 on obesity and non-alcoholic fatty liver disease Abstract].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2018
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 1 country.

Sara García-SerranoCIBER Diabetes and Associated Metabolic Disorders, ISCIII, Spain.
Inmaculada Moreno-Santos
Lourdes Garrido-Sánchez
Carolina Gutierrez-Repiso
Jose M García-Almeida
Juan García-Arnés
Jose Rivas-Marín
Jose L Gallego-Perales
Eva García-Escobar
Gemma Rojo-Martinez
Francisco Tinahones
Federico Soriguer
Manuel Macias-Gonzalez
Eduardo García-Fuentes
Hospital Clínico Universitario Virgen de la Victoria · ESUniversidad de Málaga · ESCentro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas · ESInstituto de Salud Carlos III · ESSpanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Animal studies have revealed the association between stearoyl-CoA desaturase 1 (SCD1) and obesity and insulin resistance. However, only a few studies have been undertaken in humans. We studied SCD1 in visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) from morbidly obese patients and their association with insulin resistance, sterol regulatory element binding protein-1 (SREBP-1) and ATPase p97, proteins involved in SCD1 synthesis and degradation. The insulin resistance was calculated in 40 morbidly obese patients and 11 overweight controls. Measurements were made of VAT and SAT SCD1, SREBP-1 and ATPase p97 mRNA expression and protein levels. VAT and SAT SCD1 mRNA expression levels in the morbidly obese patients were significantly lower than in the controls (P = 0.006), whereas SCD1 protein levels were significantly higher (P < 0.001). In the morbidly obese patients, the VAT SCD1 protein levels were decreased in patients with higher insulin resistance (P = 0.007). However, SAT SCD1 protein levels were increased in morbidly obese patients with higher insulin resistance (P < 0.05). Multiple linear regressions in the morbidly obese patients showed that the variable associated with the SCD1 protein levels in VAT was insulin resistance, and the variables associated with SCD1 protein levels in SAT were body mass index (BMI) and ATPase p97. In conclusion, these data suggest that the regulation of SCD1 is altered in individuals with morbid obesity and that the SCD1 protein has a different regulation in the two adipose tissues, as well as being closely linked to the degree of insulin resistance.

Indexed as

Insulin ResistanceAdenosine TriphosphatasesAdipose TissueAdultAgedAnimalsBlotting, WesternFemaleHumansIntra-Abdominal FatLinear ModelsMaleMiddle AgedMultivariate AnalysisNuclear ProteinsObesity, MorbidAdenosine TriphosphatasesNuclear Proteinsp97 ATPaseProtein IsoformsRNA, MessengerSCD1 protein, humanSREBF1 protein, humanStearoyl-CoA DesaturaseSterol Regulatory Element Binding Protein 1

Identifiers

PMID21060977
PMCPMC3060976
OpenAlexW2216457179

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.